| MORNING PROGRAM | |
| 8:30 A.M. | WELCOME by: Philippe Nantermet, Merck & Co., Matteo Pasquali, Chairman, Department of Chemistry, and Peter Rossky, Dean, School of Natural Sciences |
| 9:00 A.M. | Nicos Petasis, University of Southern California Nature’s Ending of Inflammation |
| 9:30 A.M. | Adrian Smith, formerly of Amgen Exploring the Unfolded Protein Response (UPR) with Selective PERK Inhibitors |
| 10:00 A.M. | Erik Sorensen, Princeton University Toward nature-inspired, catalytic hydrogen atom transfer reactions |
| 10:30 A.M. | BREAK |
| 10:45 A.M. | Emmanuel Theodorakis, University of California, San Diego Natural Products: From Flask to Cell |
| 11:15 A.M. | David Hepworth, Pfizer Selective Kinase Inhibitors for the Treatment of Autoimmune Diseases |
| 11:45 A.M. | Phil Baran, The Scripps Research Institute Translational Chemistry |
| AFTERNOON PROGRAM | |
| 2:00 P.M. | Helen Mitchell, Merck & Co Optimization of Selective TrkA Inhibitors for the Treatment of Pain |
| 2:30 P.M. | Scott Snyder, University of Chicago Exploring Chemoselectivity through Natural Product Total Synthesis |
| 3:00 P.M. | BREAK |
| 3:15 P.M. | A.J. Roecker, Merck & Co. Orexin Receptor Antagonist Research at Merck: From Genetic Target Validation to New Therapeutic Agents for the Treatment of Insomnia |
| 3:45 P.M. | Kevin Cole, Eli Lilly & Co. A Journey in Pharmaceutical Process Chemistry |
| 4:15 P.M. | Adrian Ortiz, Bristol-Myers Squibb Discovery of an Innovative and Stereoselective Syntheses of BMS-986001 |
| 4:45 P.M. | David Sarlah, University of Illinois at Urbana-Champaign Dearomative Functionalization with Arenophiles |
| 6:45 P.M. | Special Dinner Lecture by E.J. Corey, Harvard University |
| 7:30 P.M. | REMARKS by Nicolaou Family and Alumni |
| 9:00 P.M. | THANK YOU by K.C. Nicolaou, Rice University |
NOTE: Agenda subject to change. Last updated September 28, 2016. Please contact kcngroup@rice.edu with questions.